Previous Article | Next Article ![]()
Journal of Virology, July 2001, p. 6625-6634, Vol. 75, No. 14
Department of Biochemistry and Molecular
Biology, Baylor College of Medicine, Houston, Texas
77030,1 and Departments of
Pediatrics2 and Microbiology and
Immunology4 and Elizabeth B. Lamb Center
for Pediatric Research,3 Vanderbilt
University School of Medicine, Nashville, Tennessee 37232
Received 20 November 2000/Accepted 13 April 2001
Reovirus virions are nonenveloped icosahedral particles consisting
of two concentric protein shells, termed outer capsid and core.
Outer-capsid protein Mammalian reoviruses are
nonenveloped, icosahedral viruses that contain a genome of 10 double-stranded RNA gene segments. Reovirus particles consist of an
outer-capsid shell that surrounds a central core, which contains the
viral genome. By cryoelectron microscopy (cryo-EM) and
three-dimensional image analysis, virions of reovirus strain type 1 Lang (T1L) are ~850 Å in diameter and are notable for 600 finger-like projections, which correspond to the The As determined by X-ray crystallography, the Monoclonal antibodies (MAbs) specific for each of the reovirus
outer-capsid proteins have been isolated and characterized (6,
40). In this study, we performed experiments to determine the mechanism by
which Cells, viruses, and antibodies.
Murine L cells were grown in
suspension culture in Joklik's modified Eagle's minimal essential
medium (Irvine Scientific, Santa Ana, Calif.) supplemented to contain
5% fetal bovine serum (Intergen, Purchase, N.Y.), 2 mM
L-glutamine, 100 U of penicillin per ml, 100 µg of
streptomycin per ml, and 0.25 g of amphotericin per ml (Irvine).
Reovirus strain T3D is a laboratory stock. Purified virion preparations
were made using second-passage L-cell lysate stocks of
twice-plaque-purified reovirus as previously described (19).
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.14.6625-6634.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
A Monoclonal Antibody Specific for Reovirus Outer-Capsid Protein
3 Inhibits
1-Mediated Hemagglutination by Steric
Hindrance
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
1 is the viral attachment protein and binds
carbohydrate molecules on the surface of host cells. Monoclonal
antibody (MAb) 4F2, which is specific for outer-capsid protein
3,
blocks the binding of
1 protein to sialic acid and inhibits
reovirus-induced hemagglutination (HA). To determine whether MAb 4F2
inhibits HA by altering
1-
3 interactions or by steric hindrance,
we analyzed the effect of 4F2 immunoglobulin G (IgG) and Fab fragments
(Fabs) on HA induced by reovirus strain type 3 Dearing (T3D). The
concentration of 4F2 IgG sufficient to inhibit T3D-induced HA was 12.5 µg per ml, whereas that of Fabs was >200 µg per ml. Dynamic light
scattering analysis showed that at the concentration of IgG sufficient
to inhibit HA, virion-antibody complexes were monodispersed and not
aggregated. The affinity of 4F2 Fabs for T3D virions was only threefold
less than that of intact IgG, which suggests that differences in HA
inhibition titer exhibited by 4F2 IgG and Fabs are not attributable to
differences in the affinity of these molecules for T3D virions. We used
cryoelectron microscopy and three-dimensional image analysis to
visualize T3D virions alone and in complex with either IgG or Fabs of
MAb 4F2. IgG and Fabs bind the same site at the distal portion of
3,
and binding of IgG and Fabs induces identical conformational changes in
outer-capsid proteins
3 and µ1. These results suggest that MAb 4F2
inhibits reovirus binding to sialic acid by steric hindrance and
provide insight into the conformational flexibility of reovirus outer-capsid proteins.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
3 protein
(14). The 600 copies of
3 interdigitate with a more
internal layer composed of 600 copies of µ1 protein. These proteins
form the outer capsid. Large turrets composed of pentamers of
2
protein are located at each of the icosahedral fivefold axes, and a
small density at the center of each fivefold axis corresponds to viral
attachment protein
1.
1 protein is comprised of an amino-terminal fibrous tail, which
anchors the protein into the virion, and a compact, carboxy-terminal globular head (3, 8, 17, 19). Two discrete
receptor-binding domains have been identified for reovirus strain type
3 Dearing (T3D)
1. Sequences in the T3D
1 head domain bind
junction adhesion molecule (4), an integral tight junction
protein expressed on epithelial and endothelial cells (28,
30). Sequences in the T3D
1 tail domain bind sialic acid
residues on glycosylated cell-surface molecules of erythrocytes and
nucleated cells (9, 10, 13, 32, 35). Binding to sialic
acid is required for the capacity of T3D to produce hemagglutination
(HA) (1, 13, 20, 21, 33, 34) and to infect some types of
cells in culture (10, 35). The
1 protein in virions
appears to assume a retracted conformation (14, 19), which
might place it in a position where it could interact with
3
(40).
3 protein is composed of
two lobes organized around a central helix that spans the length of the
protein (32a). The larger and more external lobe projects
into the surrounding solvent. The smaller lobe interacts with the
core-proximal outer-capsid protein, µ1 (14). During viral disassembly in cellular endosomes, the
3 protein is removed from virions by acid-dependent proteolysis (2, 37), which is a requisite step in the penetration of reovirus into the cytoplasm (5, 22, 23, 29). Removal of
3 during viral disassembly also is hypothesized to allow a change in the conformation of
1 to a
more extended form (32). Mutations in T3D
3 determine the sensitivity of virions to proteolysis by the intestinal protease chymotrypsin (43) and the endocytic protease cathepsin L
(16). Therefore, both
1 and
3 play important roles
in reovirus entry into cells.
1-specific MAbs are serotype specific (6,
40), and some of these MAbs potently neutralize viral
infectivity in plaque-reduction neutralization assays (6, 36,
40). Type 1
1-specific MAb 5C6 (40) and type 3
1-specific MAb 9BG5 (6) bind the
1 head domain
(9) and likely mediate neutralization by blocking access
of
1 to the head receptor on host cells.
3-specific MAbs are not
serotype specific (40) and are not capable of neutralizing viral infectivity (38). However, several
3-specific
MAbs are capable of inhibiting the
1-mediated function of HA
(40). The mechanism by which a
3-specific MAb blocks
the binding of
1 to cell-surface sialic acid is not known.
3-specific MAb 4F2 inhibits the capacity of T3D to produce HA.
We analyzed the effect of intact immunoglobulin G (IgG) and Fab
fragments (Fabs) of MAb 4F2 on HA and aggregation of viral particles.
We used cryo-EM and three-dimensional image reconstruction to visualize
T3D virions, alone and in complex with either IgG or Fabs of MAb 4F2,
to investigate whether conformational alterations in outer-capsid
proteins are associated with the binding of 4F2 to
3. The results
indicate that IgG and Fabs of MAb 4F2 induce identical conformational
alterations in the reovirus outer capsid, but only IgG is capable of
inhibiting HA. At IgG concentrations sufficient to inhibit HA, viral
particles are monodispersed, as assessed by dynamic light scattering
(DLS) analysis. These findings provide strong evidence that
3-specific MAb 4F2 inhibits
1 binding to cell-surface sialic acid
by steric hindrance.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
3-specific MAb 4F2 (40), type 1
1-specific MAb
5C6 (40), and type 3
1-specific MAb 9BG5
(6) were purified from hybridoma cell supernatants by
protein A column chromatography (National Cell Culture Center, Cellex
Biosciences, Inc., Minneapolis, Minn.). Biotinylated 4F2 was generated
by incubating 2 mg of MAb 4F2 per ml with
sulfo-N-hydroxysuccinimide-biotin (Pierce, Rockford, III.),
at 0.14 mg per ml (final concentration) with antibody, at room
temperature for 2 h. Biotinylated 4F2 was dialyzed extensively against phosphate-buffered saline (PBS), and the concentration of the
biotinylated antibody was determined using the Bio-Rad DC
protein assay (Bio-Rad Laboratories, Hercules, Calif.).
Generation of Fabs of
3-specific MAb 4F2.
Fabs of MAb 4F2
were generated using an ImmunoPure Fab purification kit (Pierce). IgG
molecules of MAb 4F2 were concentrated to approximately 5 mg per ml in
PBS and digested with 83 µg of papain per ml (2.3 BAEE units per ml)
in a total volume of 1.5 ml. Fabs were recovered by protein A column
chromatography, dialyzed against PBS, and concentrated by Centricon
(Millipore Corporation, Bedford, Mass.) centrifugation. Concentrations
of IgG and Fabs of MAb 4F2 were determined by the Bio-Rad DC
protein assay.
HAI Assays. Purified T3D virions (4 HA units [1011 particles]) in a volume of 25 µl in PBS were incubated with 0 to 200 µg of IgG or Fabs of MAb 4F2, 5C6, or 9BG5 per ml in a volume of 25 µl in PBS at 37°C for 1 h in 96-well round-bottom microtiter plates (Corning-Costar, Cambridge, Mass.). Human type A erythrocytes were washed twice with PBS and resuspended at a concentration of 2% (vol/vol). Erythrocytes (50 µl) were added to the virion-antibody mixtures, and plates were incubated at 4°C overnight. The HA inhibition (HAI) titer was defined as the lowest concentration of antibody capable of inhibiting HA.
Affinity of IgG or Fabs of
3-specific MAb 4F2 for T3D
virions.
Enzyme immunoassay-radio immunoassay 96-well plates
(Corning-Costar) were coated with 100 µl of purified virions per well of reovirus T3D at 1012 particles per ml in
carbonate-bicarbonate coating buffer (Sigma, St. Louis, Mo.) and
incubated at room temperature for 1 h. Coated plates were washed
four times with PBS containing 0.05% Tween 20 detergent (PBS-T) and
stored at 4°C until use. A saturation curve was determined for the
binding of biotinylated 4F2 to T3D virions. Biotinylated 4F2 (0.0005 to
50 µg per ml) was added to virion-coated wells at 100 µl per well,
and plates were incubated with rocking at room temperature for 30 min.
Wells were washed four times with PBS-T to remove unbound biotinylated
4F2. Avidin-biotinylated horseradish peroxidase complex (ABC) reagent
(Vector Laboratories, Burlingame, Calif.) was prepared according to the
manufacturer's instructions. ABC reagent was added at 100 µl per
well and incubated with rocking at room temperature for 30 min. Wells
were washed four times with PBS-T to remove unbound ABC reagent. One 10 mg 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) tablet was dissolved in 100 ml of 0.05 M phosphate-citrate buffer (Sigma), and
30% H2O2 was added just prior to use (2.5 µl
per 10 ml). ABTS-H2O2 substrate was added at
100 µl per well and incubated without rocking at room temperature in
the dark for 10 min, followed by measurement of absorbance at 405 nm.
The concentration of biotinylated 4F2 resulting in 50% saturation (0.5 µg per ml) was used in competition assays in which various
concentrations of unbiotinylated IgG and Fabs of MAb 4F2 were used to
compete the binding of biotinylated 4F2 to T3D virions. Competition
assays were performed using a 1:2 dilution of ABC reagent, and
virion-antibody mixtures were incubated with ABC reagent for 15 min.
Preparation of virion-antibody complexes for cryo-EM.
Virions of reovirus T3D (1013 per ml) were incubated with
either IgG or Fabs of MAb 4F2 at a ratio of five antibody molecules for
each
3 protein (600 copies per virion). Samples were incubated at
room temperature for 2 h followed by overnight at 4°C and were examined by negative-stain electron microscopy to assess particle concentration and estimate antibody binding. Samples then were frozen
for cryo-EM.
DLS. Virions were incubated with 4F2 IgG at the same concentrations used in the HAI assays. After incubation at 37°C for 1 h, samples were analyzed for DLS using a DynaPro-801 (Protein Solutions, Inc., Charlottesville, Va.) to determine the dispersion characteristics of the particles.
Cryo-EM.
Specimen preparation for cryo-EM was performed
using standard procedures (15). A 4-µl aliquot of each
specimen (virions, 4F2 IgG-virion complexes, or 4F2 Fab-virion
complexes) was applied to one side of a holey carbon grid. The grid was
then blotted and plunged into a bath of liquid ethane (
180°C). The
frozen-hydrated sample was transferred to a pre-cooled GATAN cryoholder
(GATAN, Inc., Pleasanton, Calif.) and imaged using a JEOL 1200 transmission electron microscope (JEOL USA, Inc., Peabody, Mass.),
operated at 100 kV and maintained at a specimen temperature of
163°C. Regions of interest were imaged at ×30,000 magnification
with an electron dose of 5 electrons/Å2. From
each region, a focal pair was recorded with intended defocus values of
1 and 2 µm. The electron images were recorded with a 1-s exposure on
Kodak SO-163 film (Kodak, Rochester, N.Y.). Film was developed in Kodak
D-19 developer at 21°C for 12 min and fixed in Kodak fixer at 21°C
for 10 min.
Three-dimensional image reconstructions. Micrographs were selected based on particle concentration, quality of ice, and appropriate defocus conditions. Images were digitized on a Zeiss SCAI microdensitometer (Carl Zeiss, Inc., Englewood, Colo.), using a 7-µm step size. Pixels were averaged to give a 14-µm step size that corresponded to 4.67 Å per pixel in the object. Particles were boxed with an area of 256 by 256 pixels. Determination of orientational parameters, refinement of these parameters, and three-dimensional reconstructions were performed using the ICOS Toolkit software suite (27). Orientations of the particles were determined using the common lines approach (11) and refined by the cross-common lines method (18). Three-dimensional image reconstructions from a set of particles that adequately represented the icosahedral asymmetric unit were computed by cylindrical expansion methods (11). The further-from-focus micrograph in each focal pair was processed first to obtain a low-resolution reconstruction. This reconstruction then was used to determine correct orientations for particles imaged in the corresponding closer-to-focus micrograph.
Image reconstructions were computed to a resolution within the first zero of the contrast transfer function (CTF) of the corresponding micrograph. Defocus values were determined from CTF ring positions in the sum-of-particle Fourier transforms. Defocus values of various specimens in the closer-to-focus micrographs ranged from 1.2 to 1.4 µm. Image reconstructions were corrected for the effects of the CTF using previously described procedures (46). Final resolution for each reconstruction was determined by Fourier ring correlation analysis (39). Image reconstructions were computed to ~23-Å resolution for comparative analysis. Contour levels in each reconstruction were chosen to represent equal volumes between radii at ~305 Å and at ~425 Å. Reconstructions were viewed on a Silicon Graphics workstation (SGI, Mountain View, Calif.) using IRIS Explorer version 3.5 software (Numerical Algorithms Group, Inc., Oxford, United Kingdom).Fitting of X-ray structures into the cryo-EM
reconstructions.
The X-ray coordinates for
3 (32a)
and representative Fab, 1clz (24), were initially
rigid-body fitted into their respective portions of the cryo-EM density
maps by visual inspection using the graphical program O
(25). Subsequent refinements were performed using the
Situs program package, a rigid-body correlation fitting procedure that
allows the fitting of X-ray structures into low-resolution cryo-EM
density maps (45). The fully refined positions of
3 and
Fab were displayed using Ribbons version 2.85 software
(7).
| |
RESULTS |
|---|
|
|
|---|
Fabs of MAb 4F2 do not inhibit HA by T3D virions.
The
3-specific MAb 4F2 is capable of inhibiting HA by reovirus strain
T3D (40). To determine whether Fabs of MAb 4F2 are capable
of inhibiting T3D-induced HA, HAI assays were performed using 4F2 IgG
and Fabs. Type 3
1-specific MAb 9BG5 and type 1
1-specific MAb
5C6 were used as isotype-matched specificity controls. IgG molecules of
MAb 9BG5 are capable of inhibiting HA by T3D, whereas those of MAb 5C6
are not (40). T3D virions were incubated with increasing
concentrations of IgG and Fabs of each antibody and tested for the
capacity to produce HA (Fig. 1). 4F2 IgG
inhibited HA at all concentrations of
12.5 µg per ml. In contrast,
4F2 Fabs did not inhibit HA at concentrations of
200 µg per ml,
which was the highest concentration of antibody tested. Therefore, the HAI titer for 4F2 IgG was at least 16-fold lower than that for 4F2
Fabs. HAI titers for 9BG5 Fabs were equivalent to those of intact IgG,
and both IgG and Fabs of MAb 5C6 did not produce HAI at any
concentration of antibody used. These results indicate that, unlike
IgG, Fabs of MAb 4F2 do not interfere with the binding of T3D to
erythrocytes.
|
IgG and Fabs of MAb 4F2 bind T3D virions with similar
affinity.
To determine whether differences in the capacity of IgG
and Fabs of MAb 4F2 to inhibit T3D-induced HA are associated with differences in their affinity for virions, we tested the capacity of
each to bind T3D virions by using an indirect enzyme-linked immunosorbent competition assay. Purified T3D virions were coated onto
96-well plates, and then biotinylated 4F2 IgG was added. Increasing
concentrations of unbiotinylated 4F2 IgG and Fabs
were used to compete the binding of biotinylated 4F2 to T3D
virions, and an avidin-biotin-conjugated enzyme detection method
was used to quantitate bound biotinylated 4F2 after competition
(Fig. 2). Results from three
independent experiments showed that 4F2 IgG and Fabs bound
T3D virions with similar affinity. At lower concentrations (between 0 and 0.01 µM), IgG and Fabs did not compete the binding of
biotinylated 4F2 to T3D. At higher concentrations (between 0.01 and 1 µM), both IgG and Fabs competed the binding of biotinylated 4F2 in a
dose-dependent manner. The concentration of IgG required to compete
50% of the binding of biotinylated IgG to T3D was 0.07 µM,
whereas that of Fabs was 0.4 µM, or approximately sixfold more.
These results indicate that differences in HAI exhibited by 4F2 IgG and
Fabs are not attributable to differences in their binding affinity for
virions.
|
4F2 IgG does not produce aggregation of reovirus virions. To determine whether MAb 4F2 mediates HAI by producing aggregation of viral particles, we used DLS to analyze T3D virions alone and in complex with MAb 4F2. At the minimum concentration of 4F2 IgG sufficient to inhibit HA (12.5 µg per ml), individual virion-antibody complexes were found to be monodispersed and consistent with the size of virion-antibody complexes as determined by cryo-EM (data not shown). DLS analysis of Fab-bound virions also demonstrated monodispersed virion-antibody complexes, albeit of a slightly smaller size consistent with the absence of Fc domains in the antibody molecules. These results strongly suggest that MAb 4F2 does not mediate HAI by antibody-induced aggregation of viral particles.
Cryo-EM of native virions and antibody-bound virions.
To
determine whether differences in the capacity of 4F2 IgG and Fabs to
inhibit HA by T3D are due to antibody-induced alterations in the
conformation of viral outer-capsid proteins, we used cryo-EM and
three-dimensional image analysis to compare the structures of native
virions and virions bound by either intact IgG or Fabs. Cryo-images of
unstained frozen-hydrated native virions (Fig. 3A), IgG-bound virions (Fig. 3B), and
Fab-bound virions (Fig. 3C) were collected at ×30,000 magnification.
Native virion particles and virion-antibody complexes were randomly
oriented within a thin layer of vitreous ice. Finger-like projections
corresponding to
3 protein were observed in the native virion
structures. Due to the number of
3 molecules on the surface of the
virion (600 copies [14]) and the affinity of MAb 4F2 for
3 protein (40), the
3 projections were
completely obscured after incubation of virions with either IgG
or Fabs of MAb 4F2. Both forms of antibody produced a halo of
density surrounding the virion structures. Incubation of virions
with either IgG or Fabs of MAb 4F2 resulted in an approximately 26 or
19% increase in particle diameter, respectively, compared to the
diameter of native virions. This increase in diameter rendered
antibody-bound virions easily distinguishable from unbound virions.
Native and antibody-bound virions were digitally extracted from each
micrograph and used for image reconstructions. Inverse eigenvalues for
95% of the particles were below 0.1, indicating adequate sampling for
the computed resolutions.
|
Structures of IgG-bound and Fab-bound virions.
Isosurface
image reconstructions of native T3D virions (computed to 23-Å
resolution using 183 particles), IgG-bound virions (computed to
26-Å resolution using 49 particles), and Fab-bound virions
(computed to 23-Å resolution using 220 particles) are shown
in Fig. 4A to C, respectively. In
contrast to the cryo-images of native and Fab-bound virions, there were
fewer particles observed in the cryo-images of IgG-bound virions,
although the viral particle concentration was equivalent in each case.
The apparent discrepancy in particle number might be attributable to
either a change in the surface properties of the IgG-bound virions or
loss of virion-antibody complexes during cryo-specimen preparation. As
a result, fewer particles were used in the image reconstruction of
IgG-bound virions. The IgG-bound virion has a larger diameter than the
Fab-bound virion due to the Fc portion of the antibody. However, at the radius corresponding to the antibody Fc fragment, the mass density is
not well resolved in the reconstruction. Therefore, data beyond a
radius of 480 Å were removed in both the IgG-bound and
Fab-bound virion reconstructions to reveal density due only to the Fab
portion of the antibody. The IgG-bound and Fab-bound virions have
similar patterns of antibody attachment to
3 protein. Individual
Fabs could not be visualized but instead formed continuous rings of mass density surrounding each of the local threefold axes. However, at
the fivefold axes, bilobed structures bound to the distal tips of the
3 protein were clearly resolved. These
3-binding structures appeared to be of the correct size and shape of Fabs.
|
Placement of the
3 structure into native and Fab-bound virion
density maps.
The X-ray coordinates of
3 protein
(32a) were manually placed into four projections of
3
in the native virion density adjacent to a fivefold axis (Fig. 5A and
B). The projections are designated 1 through 4 in Fig. 5A to indicate position relative to the fivefold axis. The density corresponding to each projection was extracted separately from both native virions and Fab-bound virions. The initial
fitting indicated that the
3 structure could be placed into the
cryo-EM density in two different orientations related by a 180°
rotation around the long axis of the molecule. We used a quantitative
method to refine the placement of the
3 structure in native and
Fab-bound densities. The manually placed coordinates were rigid-body
fitted using the Situs program package, which produces placement of
multiple orientations with a score. In the native virion density, the
four
3 molecules were fitted individually with an average
cross-correlation coefficient of 0.78. The inverted fitting of the
3
protein gave a cross-correlation coefficient of 0.70. The orientation
that provided the higher cross-correlation coefficient is in agreement
with that previously reported (32a) (Fig. 5C). The larger
of the two
3 lobes (residues 91 to 286 and 337 to 365) is distal to
the surface of the virion and contains a region of
-helix that
protrudes away from the virion particle. The smaller lobe (residues 1 to 90 and 287 to 336) is more virion proximal and interacts with the
underlying µ1 protein layer.
|
3 into the native density was next examined for the
quality of fit into the
3 density of Fab-bound virions. For each of
the four projections of
3 examined, the
3 molecules in Fab-bound
virions are in slightly different conformations but are oriented
similarly to native virions (data not shown). At the resolution of the
reconstructions obtained in this study, it was not possible to
determine whether the entire
3 molecule moves as a single unit, or
whether small conformational changes occur once Fabs have bound. The
3 coordinates were rigid-body fitted into the Fab-bound virion
density using the Situs program package. The four projections were
fitted with an average cross-correlation coefficient of 0.70. In
comparison to the fitting of
3 in native virions, small alterations
in positions 1 and 4 and larger alterations in positions 2 and 3 were
observed in the fitting of
3 in Fab-bound virions (data not shown).
After binding of 4F2 Fabs, the
3 in position 1 rotates outward and
away from the group of four projections.
3 structures placed into
position 1 of both native virions and Fab-bound virions are shown in
Fig. 5D. These results indicate that the conformation of
3 in
Fab-bound virions is altered in comparison to native virions,
presumably as a consequence of antibody binding.
Orientation of Fabs of MAb 4F2 bound to T3D
3 protein.
Densities of Fabs at the fivefold axes correlated well with the
expected envelope of an Fab molecule. There are two lobes in an Fab:
the variable domain, which binds antigen, and the constant domain,
which is more distal to the antigen-binding epitope (12). The general structure of an Fab is highly conserved. However, the elbow
angle between the constant and variable domains can vary, as can the
loops of the antibody paratope that form the complementary-determining
region (CDR). To determine the position and orientation of 4F2 Fabs
bound to
3 protein, we used the X-ray coordinates of the 1clz Fab
(24) as a prototype to fit into the reconstruction of
antibody-bound virions. Atomic coordinates of the 1clz Fab fragment
were first manually placed into the cryo-EM reconstruction of the
Fab-bound virions. The fitting was refined using the Situs program
package, which gave a cross-correlation coefficient of 0.66. Both the
variable and constant domains of the Fab were fitted unambiguously into
the cryo-EM reconstruction of the Fab-bound virion (Fig.
6, top). The CDR loops of the fitted Fab
were in close proximity to a virion-distal
-helix, which contains
amino acid 116. This amino acid lies directly beneath the bound Fab and
is in close (~5 Å) contact with the fitted Fab coordinates.
Comparative sequence analysis of
3 in reovirus strains that differ
in the capacity to be bound by MAb 4F2 implicated residue 116 as
important for the binding of 4F2 to
3 (26).
|
3 protein at the same site.
At locations in the Fab-virion reconstruction other than in the
immediate vicinity of the fivefold axes, it was more difficult to
accurately position the Fab structure in the cryo-EM density. In an
attempt to evaluate the percent occupancy of Fabs bound to T3D, we
placed the Fab coordinates into the cryo-EM density at the hexameric
locations around an icosahedral threefold axis in such a way as to
account for the continuous tubes of antibody density (data not shown).
This analysis suggests that Fabs are bound at an angle to the surface
of
3 and that the sides of each Fab come into close contact with
neighboring Fabs. If a very tight, antiparallel packing arrangement is
assumed, Fabs were determined to be capable of packing into the density
with full occupancy.
Conformational changes close to the
3 protein and Fab variable
domain interface.
To determine whether the binding of IgG and Fabs
of MAb 4F2 to T3D virions results in conformational changes in viral
outer-capsid proteins, we analyzed cross sections of the native and
antibody-bound virion reconstructions at various radii. Radial sections
of antibody-bound virions near the top of the
3 protein, at a radius
of ~407 Å, revealed a conformational change compared with
native virions. In native virions,
3 proteins surrounding local
sixfold axes are attached to their neighbors, forming hexameric rings
(Fig. 7A). However, in the IgG-bound and
Fab-bound virions, the hexameric rings are broken, and individual
3
proteins are distinct and separated from each other (Fig. 7B and C).
Binding of 4F2 IgG and Fabs to T3D also resulted in conformational
changes that are transferred well beneath the paratope-epitope
interface. A small but noticeable conformational change was
observed in the antibody-bound virions beneath the
3 layer. At a
radius of ~385 Å, which is within the µ1 layer
(14), antibody-bound virions contain a spur of density
that projects into a hole formed at the center of the hexameric ring of
µ1 proteins (Fig. 7E and F). This feature was consistent throughout
various contour levels and was visualized in independent
reconstructions of IgG-bound and Fab-bound virions. In native virions,
no such density was observed (Fig. 7D). Therefore, the binding of
3-specific MAb 4F2 to T3D virions induces conformational alterations
both in the
3 layer and in the more internal µ1 layer of the
virion outer capsid.
|
| |
DISCUSSION |
|---|
|
|
|---|
Studies of mechanisms by which antiviral antibodies inhibit viral
infectivity can yield an improved understanding of virus structure and
replication. Antibodies can neutralize viruses by blocking viral
binding to cell-surface receptors or cross-linking viral particles,
thereby reducing the number of infectious units (44).
Antiviral antibodies also can inhibit intracellular steps in viral
replication, such as internalization and disassembly (41).
MAb 4F2, which is specific for the reovirus
3 protein (40), inhibits the capacity of reovirus to produce HA
(40), which is a property mediated by the
1 protein
(6, 13, 31, 34, 42). This finding indicates that some
virus-specific MAbs block functions of proteins other than those to
which they bind (40). We conducted experiments to
determine mechanisms by which a
3-specific MAb inhibits a
1
function. We assessed the capacity of IgG and Fabs of MAb 4F2 to (i)
inhibit HA by T3D, (ii) produce aggregation of viral particles, and
(iii) mediate conformational alterations of viral outer-capsid
proteins. We found that IgG and Fabs induce identical conformational
changes in
3 and that neither produces particle aggregation.
However, 4F2 IgG molecules inhibit HA, whereas Fabs do not. These
results are most consistent with a steric hindrance mechanism of MAb
4F2 action.
The concentration of IgG required to inhibit T3D-induced HA was at least 16-fold less than that of Fabs, which were not capable of HAI even at the highest concentration tested. This finding is not explained by differences in the affinity of 4F2 IgG and Fabs for T3D virions. The concentration of Fabs required to compete 50% of the binding of IgG to T3D was approximately sixfold greater than that of IgG. However, since Fabs contain one binding site and IgG contains two binding sites, the concentration of Fabs required to compete IgG binding might be expected to be twice that of IgG. Therefore, the actual difference in affinity of IgG and Fabs of MAb 4F2 for T3D virions is approximately threefold. Since 4F2 Fabs did not inhibit HA at the highest concentration used in these experiments, it is possible that Fabs are actually incapable of preventing T3D-induced HA at any concentration. This conclusion seems likely since image reconstructions of Fab-bound virions indicate almost complete occupancy of 4F2-binding sites at a concentration of Fabs less than that used in the experiments to inhibit HA.
IgG and Fabs of 4F2 bound the same site on
3 in the image
reconstructions of IgG-bound and Fab-bound virions. 4F2 IgG and Fabs
that bind to hexameric rings of
3 protein, around the icosahedral threefold axes, are packed tightly together. These Fabs are bound at an
angle tangential to the virion surface, which results in neighboring
Fabs coming into close contact with each other. Such a close
association of
3-bound Fabs makes it difficult to visualize individual Fab molecules at the resolution obtained in this study. In
contrast, individual Fabs are clearly observed in the incomplete hexameric rings, which surround the fivefold axes, presumably due to
fewer
3 proteins at these locations (four versus six), with
resultant decreased crowding of bound antibodies.
Our analysis of IgG-bound and Fab-bound virion structures indicates
that at the fivefold axes, the orientation of the Fab variable domain
onto the
3 protein is identical to that of the variable domain of
IgG. This was not unexpected, since the interaction between the
variable domain and the protein epitope is not affected by cleavage of
intact IgG into Fabs (12). However, the location of the
constant domain of the Fab was not the same in the IgG-bound and
Fab-bound virion structures. In IgG-bound virions, the elbow angle of
the Fab is altered in comparison to Fab-bound virions. The elbow region
of Fabs is known to be flexible (12); therefore, it is
possible that the presence of Fc and the other Fab in the intact IgG
necessitates a small change in the elbow angle of the bound Fab for an
optimal interaction with the virion. Torsional alterations also can be
accommodated at the hinge region of the antibody, which is where two
Fabs connect the Fc portion (12). The Fc and the unbound
Fab portions are not resolved in our reconstructions, indicating that
the orientations of these two portions vary considerably among the
bound IgG molecules.
Conformational changes caused by the binding of IgG and Fabs are
identical, and the most significant changes from the native virion
structure are observed in the
3 and µ1 layers. After IgG or Fab
binding, the
3 proteins no longer form continuous hexameric rings of
density but are separated from each other. It is possible that in order
to bind MAb 4F2, the
3 proteins must separate slightly. The
magnitude of these movements is likely to be limited by neighboring hexameric units of
3. A conformational change in the µ1 layer of
antibody-bound virions results in a spur of density protruding into the
hexameric ring of µ1 proteins. Although it is likely that this
density belongs to µ1, we cannot rule out the possibility that it
could originate from one of the core proteins. A similar density was
seen in a reconstruction of virions of reovirus strain T1L in the
absence of antibody binding (14). This result is in
contrast to the image reconstructions of native T3D virions obtained in
this study, which suggests that a strain-specific polymorphism exists
in the appearance of a central density in the hexameric arrangement of
µ1 proteins. Nonetheless, our findings show that antibody binding to
the viral surface can induce conformational changes well beneath the
antibody-protein interface.
Since the binding of IgG and Fabs of MAb 4F2 to
3 protein induces
identical conformational changes in the virus structure, the
differences in HAI capacity of 4F2 IgG and Fabs cannot be attributed to
structural alterations caused by these molecules. We thought it
possible that aggregation of IgG-bound particles might contribute to
the inhibition of HA by limiting access of
1 to cell-surface sialic
acid. However, cryo-EM images of the IgG-bound virions show many
well-decorated particles that are clearly separated from neighboring
virions. Furthermore, at the concentration of 4F2 IgG sufficient to
inhibit HA, virion-antibody complexes were well dispersed, as assessed
by DLS experiments. These results exclude the possibility that
4F2-mediated HAI is due to either alteration in
1-
3 interactions
or aggregation of IgG-bound virions. Instead, our data provide strong
evidence that MAb 4F2 inhibits HA by steric hindrance of
1-sialic
acid interactions.
How does a
3-specific MAb sterically hinder the capacity of
1 to
bind cell-surface sialic acid? We propose a model for the possible
position of the unbound Fab arms and the Fc portions of MAb 4F2 bound
to virions that is consistent with a steric hindrance mechanism of HAI
(Fig. 8). When the X-ray structure of the
Fab portion of an entire IgG is superimposed onto the fitted Fab, the
Fc portion of the antibody would lie almost parallel to the
2 turret
and the unbound Fab arm would likely project radially away from the
viral particle. The Fc portions of bound IgG molecules would not
entirely close the turret but would leave a gap of ~50 Å at
the center. The maximum height of intact IgG from the base of the
turret, considering possible conformational flexibility of the Fab and
Fc portions of the molecule, would be ~155 Å. In its fully
extended conformation, purified
1 is ~480 Å in length
(17). The domain in T3D
1 that binds sialic acid is located in the fibrous tail (9, 10, 13), ~225
Å from the virion-proximal base (10, 17). If
virion-associated
1 were in an extended conformation, neither Fabs
nor IgG molecules would be expected to hinder access to this site, and
neither should inhibit HA activity. However, 4F2 IgG molecules but not
Fabs inhibit HA. Hence, our findings are in agreement with previous
observations that
1 is not fully extended when bound to virions
(14, 19). The Fc portions that are postulated to project
horizontally above the turret would likely mask the
1 sialic
acid-binding domain but not the head-receptor-binding domain since 4F2
IgG molecules do not neutralize viral infectivity (38). In
Fab-bound virions, the top of the turret is more accessible, and we
propose that
1 can still interact with cell-surface sialic acid
after Fab binding. Therefore, we conclude that HA inhibition by 4F2 is
most likely due to steric hindrance of the
1 sialic acid-binding
domain by the Fc portion of intact IgG.
|
The cross-correlation fitting using the Situs program package provided
an optimal placement of the X-ray coordinates for both the
3 protein
and an Fab molecule into their respective densities in the image
reconstruction of Fab-bound virions. Examination of the
3 and Fab
X-ray coordinates fitted into the Fab-bound virion reconstruction
allowed us to define the 4F2 epitope, which contains an
-helix of
3 that is positioned almost parallel to the surface of the virus.
This helix includes amino acid 116, which has been shown to influence
the capacity of MAb 4F2 to bind reovirus field isolate strains
(26).
Results reported here indicate that the binding of reovirus
outer-capsid protein
3 by MAb 4F2 inhibits HA induced by T3D
1
protein through steric hindrance and that antibody binding of
3
results in conformational changes in both the
3 and µ1 protein
layers of the reovirus outer capsid. Further insight into mechanisms by
which antibodies are capable of inhibiting the binding of virus to
cell-surface receptors may contribute to the development of antiviral
vaccines and therapeutics. Moreover, elucidation of conformational
changes induced by the binding of antibodies to viral particles
provides an appreciation for the flexibility of viral capsids and
contributes to a better understanding of the dynamic nature of
nonenveloped viruses.
| |
ACKNOWLEDGMENTS |
|---|
We thank Jim Chappell and Greg Wilson for careful review of the
manuscript and Max Nibert for essential discussions. We express our
appreciation to Ken Tyler for providing the 4F2 hybridoma and to Steve
Harrison for providing the
3 X-ray coordinates prior to publication.
We acknowledge the National Cell Culture Center for purification of MAbs.
This work was supported by Public Health Service award AI32539 from the National Institute of Allergy and Infectious Diseases and the Elizabeth B. Lamb Center for Pediatric Research.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address for B. V. Venkataram Prasad: Department of Biochemistry and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Room N410, Houston, TX 77030-3498. Phone: (713) 798-5686. Fax: (713) 798-1625. E-mail: vprasad{at}bcm.tmc.edu. Mailing address for Terence S. Dermody: Elizabeth B. Lamb Center for Pediatric Research, Vanderbilt University School of Medicine, D-7235 MCN, Nashville, TN 37232-2581. Phone: (615) 322-2250. Fax: (615) 343-9723. E-mail: terry.dermody{at}mcmail.vanderbilt.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Armstrong, G. D., R. W. Paul, and P. W. Lee. 1984. Studies on reovirus receptors of L cells: virus binding characteristics and comparison with reovirus receptors of erythrocytes. Virology 138:37-48[CrossRef][Medline]. |
| 2. |
Baer, G. S., and T. S. Dermody.
1997.
Mutations in reovirus outer-capsid protein 3 selected during persistent infections of L cells confer resistance to protease inhibitor E64.
J. Virol.
71:4921-4928[Abstract].
|
| 3. | Banerjea, A. C., K. A. Brechling, C. A. Ray, H. Erikson, D. J. Pickup, and W. K. Joklik. 1988. High-level synthesis of biologically active reovirus protein sigma 1 in a mammalian expression vector system. Virology 167:601-612[Medline]. |
| 4. | Barton, E. S., J. C. Forrest, J. L. Connolly, J. D. Chappell, Y. Liu, F. J. Schnell, A. Nusrat, C. A. Parkos, and T. S. Dermody. 2001. Junction adhesion molecule is a receptor for reovirus. Cell 104:441-451[CrossRef][Medline]. |
| 5. |
Borsa, J.,
B. D. Morash,
M. D. Sargent,
T. P. Copps,
P. A. Lievaart, and J. G. Szekely.
1979.
Two modes of entry of reovirus particles into L cells.
J. Gen. Virol.
45:161-170 |
| 6. | Burstin, S. J., D. R. Spriggs, and B. N. Fields. 1982. Evidence for functional domains on the reovirus type 3 hemagglutinin. Virology 117:146-155[CrossRef][Medline]. |
| 7. | Carson, M. 1997. "Ribbons" Methods Enzymol. 277:493-505[CrossRef][Medline]. |
| 8. | Centonze, V. E., Y. Chen, T. F. Severson, G. G. Borisy, and M. L. Nibert. 1995. Visualization of single reovirus particles by low-temperature, high-resolution scanning electron microscopy. J. Struct. Biol. 115:215-225[CrossRef][Medline]. |
| 9. |
Chappell, J. D.,
J. Duong,
B. W. Wright, and T. S. Dermody.
2000.
Identification of carbohydrate-binding domains in the attachment proteins of type 1 and type 3 reoviruses.
J. Virol.
74:8472-8479 |
| 10. |
Chappell, J. D.,
V. L. Gunn,
J. D. Wetzel,
G. S. Baer, and T. S. Dermody.
1997.
Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein 1.
J. Virol.
71:1834-1841[Abstract].
|
| 11. |
Crowther, R. A.
1971.
Procedures for three-dimensional reconstruction of spherical viruses by Fourier synthesis from electron micrographs.
Philos. Trans. R. Soc. Lond.
261:221-230 |
| 12. | Davies, D. R., and H. Metzger. 1983. Structural basis of antibody function. Annu. Rev. Immunol. 1:87-117[CrossRef][Medline]. |
| 13. |
Dermody, T. S.,
M. L. Nibert,
R. Bassel-Duby, and B. N. Fields.
1990.
A 1 region important for hemagglutination by serotype 3 reovirus strains.
J. Virol.
64:5173-5176 |
| 14. |
Dryden, K. A.,
G. Wang,
M. Yeager,
M. L. Nibert,
K. M. Coombs,
D. B. Furlong,
B. N. Fields, and T. S. Baker.
1993.
Early steps in reovirus infection are associated with dramatic changes in supramolecular structure and protein conformation: analysis of virions and subviral particles by cryoelectron microscopy and image reconstruction.
J. Cell Biol.
122:1023-1041 |
| 15. | Dubochet, J., M. Adrian, J. J. Chang, J. C. Homo, J. Lepault, A. W. McDowall, and P. Schultz. 1988. Cryo-electron microscopy of vitrified specimens. Q. Rev. Biophys. 21:129-228[Medline]. |
| 16. |
Ebert, D. H.,
J. D. Wetzel,
D. E. Brumbaugh,
S. R. Chance,
L. E. Stobie,
G. S. Baer, and T. S. Dermody.
2001.
Adaptation of reovirus to growth in the presence of protease inhibitor E64 segregates with a mutation in the carboxy terminus of viral outer-capsid protein 3.
J. Virol.
75:3197-3206 |
| 17. |
Fraser, R. D.,
D. B. Furlong,
B. L. Trus,
M. L. Nibert,
B. N. Fields, and A. C. Steven.
1990.
Molecular structure of the cell-attachment protein of reovirus: correlation of computer-processed electron micrographs with sequence-based predictions.
J. Virol.
64:2990-3000 |
| 18. | Fuller, S. D. 1987. The T=4 envelope of Sindbis virus is organized by interactions with a complementary T=3 capsid. Cell 48:923-934[Medline]. |
| 19. |
Furlong, D. B.,
M. L. Nibert, and B. N. Fields.
1988.
Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles.
J. Virol.
62:246-256 |
| 20. | Gentsch, J. R., and A. F. Pacitti. 1987. Differential interaction of reovirus type 3 with sialylated receptor components on animal cells. Virology 161:245-248[CrossRef][Medline]. |
| 21. |
Gentsch, J. R., and A. F. Pacitti.
1985.
Effect of neuraminidase treatment of cells and effect of soluble glycoproteins on type 3 reovirus attachment to murine L cells.
J. Virol.
56:356-364 |
| 22. |
Hooper, J. W., and B. N. Fields.
1996.
Monoclonal antibodies to reovirus 1 and µ1 proteins inhibit chromium release from mouse L cells.
J. Virol.
70:672-677[Abstract].
|
| 23. | Hooper, J. W., and B. N. Fields. 1996. Role of the µ1 protein in reovirus stability and capacity to cause chromium release from host cells. J. Virol. 70:459-467[Abstract]. |
| 24. | Jeffrey, P. D., J. Bajorath, C. Y. Chang, D. Yelton, I. Hellstrom, K. E. Hellstrom, and S. Sheriff. 1995. The x-ray structure of an anti-tumour antibody in complex with antigen. Nat. Struct. Biol. 2:466-471[CrossRef][Medline]. |
| 25. | Jones, T. A., J.-Y. Zou, S. W. Cowan, and M. Kjeldgaard. 1991. Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallographa 47:110-119. |
| 26. | Kedl, R., S. Schmechel, and L. Schiff. 1995. Comparative sequence analysis of the reovirus S4 genes from 13 serotype 1 and serotype 3 field isolates. J. Virol. 69:552-559[Abstract]. |
| 27. | Lawton, J. A., and B. V. V. Prasad. 1996. Automated software package for icosahedral virus reconstruction. J. Struct. Biol. 116:209-215[CrossRef][Medline]. |
| 28. | Liu, Y., A. Nusrat, F. J. Schnell, T. A. Reaves, S. Walsh, M. Ponchet, and C. A. Parkos. 2000. Human junction adhesion molecule regulates tight junction resealing in epithelia. J. Cell Sci. 113:1-11[Abstract]. |
| 29. |
Lucia-Jandris, P.,
J. W. Hooper, and B. N. Fields.
1993.
Reovirus M2 gene is associated with chromium release from mouse L cells.
J. Virol.
67:5339-5345 |
| 30. |
Martin-Padura, I.,
S. Lostaglio,
M. Schneemann,
L. Williams,
M. Romano,
P. Fruscella,
C. Panzeri,
A. Stoppacciaro,
L. Ruco,
A. Villa,
D. Simmons, and E. Dejana.
1998.
Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration.
J. Cell Biol.
142:117-127 |
| 31. |
Masri, S. A.,
L. Nagata,
D. C. Mah, and P. W. Lee.
1986.
Functional expression in Escherichia coli of cloned reovirus S1 gene encoding the viral cell attachment protein 1.
Virology
149:83-90[CrossRef][Medline].
|
| 32. |
Nibert, M. L.,
J. D. Chappell, and T. S. Dermody.
1995.
Infectious subvirion particles of reovirus type 3 Dearing exhibit a loss in infectivity and contain a cleaved 1 protein.
J. Virol.
69:5057-5067[Abstract].
|
| 32a. |
Olland, A. M.,
J. Jané-Valbuena,
L. A. Schiff,
M. L. Nibert, and S. C. Harrison.
2001.
Structure of the reovirus outer capsid and dsRNA-binding protein 3 at 1.8 Å resolution.
EMBO
20:979-989[CrossRef][Medline].
|
| 33. |
Paul, R. W.,
A. H. Choi, and P. W. K. Lee.
1989.
The -anomeric form of sialic acid is the minimal receptor determinant recognized by reovirus.
Virology
172:382-385[CrossRef][Medline].
|
| 34. | Paul, R. W., and P. W. K. Lee. 1987. Glycophorin is the reovirus receptor on human erythrocytes. Virology 159:94-101[CrossRef][Medline]. |
| 35. |
Rubin, D. H.,
J. D. Wetzel,
W. V. Williams,
J. A. Cohen,
C. Dworkin, and T. S. Dermody.
1992.
Binding of type 3 reovirus by a domain of the 1 protein important for hemagglutination leads to infection of murine erythroleukemia cells.
J. Clin. Investig.
90:2536-2542.
|
| 36. | Spriggs, D. R., and B. N. Fields. 1982. Attenuated reovirus type 3 strains generated by selection of haemagglutinin antigenic variants. Nature 297:68-70[CrossRef][Medline]. |
| 37. |
Sturzenbecker, L. J.,
M. Nibert,
D. Furlong, and B. N. Fields.
1987.
Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle.
J. Virol.
61:2351-2361 |
| 38. |
Tyler, K. L.,
M. A. Mann,
B. N. Fields, and H. W. Virgin, IV.
1993.
Protective anti-reovirus antibodies and their effects on viral pathogenesis.
J. Virol.
67:3446-3453 |
| 39. | van Heel, M. 1987. Similarity measures between images. Ultramicroscopy 21:456-469. |
| 40. |
Virgin, H. W., IV,
M. A. Mann,
B. N. Fields, and K. L. Tyler.
1991.
Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action.
J. Virol.
65:6772-6781 |
| 41. |
Virgin, H. W.,
M. A. Mann, and K. L. Tyler.
1994.
Protective antibodies inhibit reovirus internalization and uncoating by intracellular proteases.
J. Virol.
68:6719-6729 |
| 42. | Weiner, H. L., R. F. Ramig, T. A. Mustoe, and B. N. Fields. 1978. Identification of the gene coding for the hemagglutinin of reovirus. Virology 86:581-584[CrossRef][Medline]. |
| 43. | Wetzel, J. D., G. J. Wilson, G. S. Baer, L. R. Dunnigan, J. P. Wright, D. S. H. Tang, and T. S. Dermody. 1997. Reovirus variants selected during persistent infections of L cells contain mutations in the viral S1 and S4 genes and are altered in viral disassembly. J. Virol. 71:1362-1369[Abstract]. |
| 44. | Whitton, J. L., and M. B. A. Oldstone. 1996. Immune responses to viruses, p. 345-374. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa. |
| 45. | Wriggers, W., R. A. Milligan, and J. A. McCammon. 1999. Situs: a package for docking crystal structures into low-resolution maps from electron microscopy. J. Struct. Biol. 125:185-195[CrossRef][Medline]. |
| 46. | Zhou, Z. H., B. V. V. Prasad, J. Jakana, F. J. Rixon, and W. Chiu. 1994. Protein subunit structures in the herpes simplex virus capsid determined from 400-kV spot-scan electron cryomicroscopy. J. Mol. Biol. 242:456-469[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»